ALX ONCOLOGY HOLDINGS INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | — | — | — | $0.0 | $0.0 |
| Operating income | -$104.0 | -$142.5 | -$170.3 | -$127.4 | -$83.6 |
| Net income | -$101.7 | -$134.8 | -$160.8 | -$123.5 | -$83.5 |
| Cash Flow Statement | |||||
| Free cash flow | -$84.4 | -$122.4 | -$131.6 | -$90.7 | -$68.8 |
Shares outstanding 138.3M · Free float 72.6%
Annual filing data through FY ended December 31, 2025; float as of October 5, 2026.